These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9689732)

  • 1. Probiotics and E. coli infections in man.
    Lodinová-Zádníková R; Sonnenborn U; Tlaskalová H
    Vet Q; 1998; 20 Suppl 3():S78-81. PubMed ID: 9689732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of care in a protected environment on the occurrence of nosocomial infections, mucosal colonization of pathogenic microflora and development of indicators of immunity in premature infants].
    Lodinová-Zádníková R; Cukrovská B; Stranák Z
    Ceska Gynekol; 2002 Apr; 67 Suppl 1():23-8. PubMed ID: 12061167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of oral colonization with probiotic E. coli strain after birth on frequency of recurrent infections, allergy and development of some immunologic parameters. Long-term studies].
    Lodinová-Zádníková R; Prokesová L; Tlaskalová H; Kocourková I; Zizka J; Stranák Z
    Ceska Gynekol; 2004 Dec; 69 Suppl 1():91-7. PubMed ID: 15748033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of oral colonization by non-pathogenic E. coli on the immune response in neonates and possibilities of its use in the prevention of nosocomial infections in children at risk].
    Lodinová-Zádníková R; Bartáková Z; Tlaskalová H
    Cesk Epidemiol Mikrobiol Imunol; 1992 Sep; 42(3):126-32. PubMed ID: 1339604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antibody response in infants after oral administration of inactivated and living E. coli vaccines and their protective effect against nosocomial infections.
    Lodinová-Zádníková R; Tlaskalová H; Korych B; Bartáková Z
    Adv Exp Med Biol; 1995; 371B():1431-8. PubMed ID: 7502832
    [No Abstract]   [Full Text] [Related]  

  • 6. The antibody response in breast-fed and non-breast-fed infants after artificial colonization of the intestine with Escherichia coli O83.
    Lodinová-Zádníková R; Slavíková M; Tlaskalová-Hogenová H; Adlerberth I; Hanson LA; Wold A; Carlsson B; Svanborg C; Mellander L
    Pediatr Res; 1991 Apr; 29(4 Pt 1):396-9. PubMed ID: 1852535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibody response in infants after colonization of the intestine with E. coli O83. Artificial colonization used as a prevention against nosocomial infections.
    Lodinová-Zádníková R; Tlaskalová H; Bartáková Z
    Adv Exp Med Biol; 1991; 310():329-35. PubMed ID: 1809007
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies in human serum and milk induced by enterobacteria and food proteins.
    Ahlstedt S; Carlsson B; Fällström SP; Hanson LA; Holmgren J; Lidin-Janson G; Lindblad BS; Jodal U; Kaijser B; Solh-Akerlund A; Wadsworth C
    Ciba Found Symp; 1977 Apr 26-28; (46):115-34. PubMed ID: 346319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Early administration of antibiotic susceptible strain of Escherichia coli in the intestine of the premature infant].
    Rastegar Lari A; Borderon JC; Gold F; Laugier J
    Res Microbiol; 1989 Jan; 140(1):69-73. PubMed ID: 2664929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Oral immunization against enteropathogenic E. coli serotypes in full-term and premature newborn infants].
    Jannuzzi C; Duillo MT; Campelli A; Bologna MP; Barbaro S
    Minerva Pediatr; 1981 May; 33(10):441-8. PubMed ID: 7019662
    [No Abstract]   [Full Text] [Related]  

  • 11. Local and systemic antibody response in infants after oral administration of inactivated enteropathogenic E. coli serotype O111 and O55.
    Lodinová-Zádníková R; Korych B; Gajdostíková K
    Folia Microbiol (Praha); 1990; 35(2):155-62. PubMed ID: 1696237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological evaluation of the efficiency of oral vaccination against enteropathogenic Escherichia coli.
    Kubinyi L; Kiss I; Lendvai KG
    Acta Microbiol Acad Sci Hung; 1972; 19(3):175-86. PubMed ID: 4594981
    [No Abstract]   [Full Text] [Related]  

  • 13. Oral administration of probiotic Escherichia coli after birth reduces frequency of allergies and repeated infections later in life (after 10 and 20 years).
    Lodinová-Zádníková R; Cukrowska B; Tlaskalova-Hogenova H
    Int Arch Allergy Immunol; 2003 Jul; 131(3):209-11. PubMed ID: 12876412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific proliferative and antibody responses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917.
    Cukrowska B; LodInová-ZádnIková R; Enders C; Sonnenborn U; Schulze J; Tlaskalová-Hogenová H
    Scand J Immunol; 2002 Feb; 55(2):204-9. PubMed ID: 11896937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
    Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
    Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The early postnatal development of salivary antibody and immunoglobulin response in children orally colonized with a nonpathogenic, probiotic strain of E. coli.
    Vancíková Z; Lodinová-Zádníková R; Radl J; Tlaskalová-Hogenová H
    Folia Microbiol (Praha); 2003; 48(2):281-7. PubMed ID: 12800517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody production by the mammary gland in mothers after artificial oral colonisation of their infants with a non-pathogenic strain E. coli 083.
    Lodinová R; Jouja V
    Acta Paediatr Scand; 1977 Nov; 66(6):705-8. PubMed ID: 335780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of the Probiotic Escherichia coli Strain A0 34/86 Resulted in a Stable Colonization of the Human Intestine During the First Year of Life.
    Micenková L; Bosák J; Smatana S; Novotný A; Budinská E; Šmajs D
    Probiotics Antimicrob Proteins; 2020 Jun; 12(2):343-350. PubMed ID: 31069717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral immunization of piglets with recombinant F4 fimbrial adhesin FaeG monomers induces a mucosal and systemic F4-specific immune response.
    Verdonck F; Cox E; Van der Stede Y; Goddeeris BM
    Vaccine; 2004 Oct; 22(31-32):4291-9. PubMed ID: 15474721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of purified colonization factor antigens (CFA/I, CFA/II) of enterotoxigenic Escherichia coli to volunteers. Response to challenge with virulent enterotoxigenic Escherichia coli.
    Evans DG; Graham DY; Evans DJ
    Gastroenterology; 1984 Oct; 87(4):934-40. PubMed ID: 6381216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.